In this issue, McClung and colleagues show that alendronate can reduce or even block the bone loss that occurs in otherwise healthy women early in menopause. But bone mass is only one of many factors contributing to fractures in postmenopausal women.
|Original language||English (US)|
|Number of pages||2|
|Journal||Annals of internal medicine|
|State||Published - Feb 15 1998|
All Science Journal Classification (ASJC) codes
- Internal Medicine